期刊档案 · PHARMACOLOGY & PHARMACY
Pharmaceutical Medicine
ISSN 1178-2595 · eISSN 1179-1993 · Springer Nature · 6 issues per year
Pharmaceutical Medicine 中科院 医学 4区（2025 年升级版），影响因子 4.7（官网公布），混合开放获取，APC 约 4,290 美元，出版商公布首次决定约 10 天，2025 年发文 235 篇，ESCI、Scopus 收录。
研究范围
研究范围与定位
Pharmaceutical Medicine 由 Springer Nature 出版，属中科院医学大类（2025 升级版4区）。按 OpenAlex 近年发文统计，该刊主要发表 Pharmaceutical Economics and Policy、Health Systems, Economic Evaluations, Quality of Life、Pharmacovigilance and Adverse Drug Reactions 等主题的论文，这 3 个主题约占 37.4%。（根据 OpenAlex 主题统计与中科院分区数据生成）
Pharmaceutical Medicine is a specialist discipline concerned with medical aspects of the discovery, development, evaluation, registration, regulation, monitoring, marketing, distribution and pricing of medicines, drug-device and drug-diagnostic combinations. The Journal disseminates information to support the community of professionals working in these highly inter-related functions. Key areas include translational medicine, clinical trial design, pharmacovigilance, clinical toxicology, drug regulation, clinical pharmacology, biostatistics and pharmacoeconomics. The Journal includes: Overviews of contentious or emerging issues. Comprehensive narrative reviews that provide an authoritative source of information on topical issues. Systematic reviews that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by PRISMA statement. Original research articles reporting the results of well-designed studies with a strong link to wider areas of clinical research.
摘自期刊官网 Aims & Scope
研究方向（LetPub）：PHARMACOLOGY & PHARMACY
主编 Sue Pochon出版商官网
编委会国家分布：未见中国大陆编委；主要国家 新西兰 11、美国 9、英国 8、德国 3、意大利 3（共 47 位编委标注了国家） 编委会 ↗出版商官网 ·
主要研究主题 OpenAlex 近年发文统计，占比为近似值
- Pharmaceutical Economics and PolicyEconomics, Econometrics and Finance17.3%
- Health Systems, Economic Evaluations, Quality of LifeEconomics, Econometrics and Finance11.2%
- Pharmacovigilance and Adverse Drug ReactionsPharmacology, Toxicology and Pharmaceutics8.9%
- Pharmaceutical studies and practicesMedicine8.9%
- Statistical Methods in Clinical TrialsMathematics5.4%
- Pharmaceutical industry and healthcarePharmacology, Toxicology and Pharmaceutics5.4%
- Science, Research, and MedicineMedicine5.3%
- Biomedical Ethics and RegulationMedicine5.3%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表（ 2025年3月升级版）医学 4 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 4 区 |
| 小类 | 药学PHARMACOLOGY & PHARMACY | 4 区 |
Top 期刊：否综述期刊：否
《新锐期刊分区表》（ 2026年3月发布）医学 3 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 3 区 |
| 小类 | 药学PHARMACOLOGY & PHARMACY | 3 区 |
Top 期刊：否综述期刊：未标注
期刊分区表（ 2023年12月旧的升级版）未收录
该期刊未被此版本分区表收录。
数据库收录
ESCIScopusLetPub
国际期刊预警名单：各版本均未列入LetPub
期刊官网自述收录
MEDLINEEmbaseCAS出版商官网
其他：Google Scholar、EBSCO、ProQuest、Dimensions、CNKI、Baidu、Naver、OCLC、Portico、CLOCKSS
期刊官网列出的收录清单，未与各数据库逐一核对；Web of Science 各子库以上方记录为准。
不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- 影响因子（出版商公布） 2025
- 4.7出版商官网 ·
- 五年影响因子（出版商公布） 2025
- 4.3出版商官网 ·
- CiteScore 2026-06
- 8.4LetPub ·
- SJR 2026-06
- 1.44LetPub ·
- SNIP 2026-06
- 1.49LetPub ·
- h-index
- 38OpenAlex ·
- i10-index
- 195OpenAlex ·
- 两年平均被引
- 1.22OpenAlex ·
- 自引率
- 6.4%LetPub ·
- Gold OA 文章占比
- 49.14%LetPub ·
发文规模
- 年文章数
- 43LetPub ·
- 年发文量（出版商公布）
- 2,025出版商官网 ·
- 年下载量（出版商公布） 2025
- 249,000出版商官网 ·
逐年发文量 OpenAlex 统计 · 累计 1,224 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 41 | 22 | 6 |
| 2025 | 235 | 30 | 154 |
| 2024 | 37 | 19 | 221 |
| 2023 | 53 | 26 | 710 |
| 2022 | 39 | 25 | 746 |
| 2021 | 43 | 25 | 374 |
不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
- 投稿到首次决定
- 10 天出版商官网 ·
- 评审方式
- 双盲同行评审出版商官网
社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
混合开放获取LetPub
订阅期刊，作者可付费选择开放获取发表。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| OpenAlex | USD 4,290 / EUR 3,290 / GBP 2,890 | — | — |
混合期刊的文章处理费仅在作者选择开放获取发表时收取；按订阅方式发表通常不收费。
费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。
投稿要求
文章类型与投稿政策（官网）
投稿准备要点4 项，摘自作者指南
- 摘要
- 150–250 词
- 参考文献格式
- 顺序编码制（按引用顺序编号）
- 推荐审稿人
- 可选
- 投稿信（Cover letter）
- 必须提供
接收的文章类型14 种
- current opinionCurrent Opinion. Word count approximately up to 3000. Places an area in perspective given that it is of current international interest and a consensus has not y…未说明篇幅
- editorialInternal Review by Editorial Staff: The journal editor will perform an initial appraisal of each manuscript. When submitting your paper, please include a coveri…未说明篇幅
- editorial/commentaryEditorial/Commentary. Word count up to 1500. A brief opinion piece on a current topic of high interest.未说明篇幅
- leading articleLeading Article. Word count up to 4000. Provides a short, balanced overview of the current state of development of an emerging area.未说明篇幅
- letter to the editorLetter to the Editor. Word count up to 1000. Comment on an article published recently in the journal; a response to the comments would normally be sought from t…未说明篇幅
- opinionPlease note: There is no limit on the number of tables, figures or references that can accompany an article. Information that is relevant but not critical to un…未说明篇幅
- original researchPlease note: There is no limit on the number of tables, figures or references that can accompany an article. Information that is relevant but not critical to un…未说明篇幅
- perspectivePlease note: There is no limit on the number of tables, figures or references that can accompany an article. Information that is relevant but not critical to un…未说明篇幅
- research articlePlease note: There is no limit on the number of tables, figures or references that can accompany an article. Information that is relevant but not critical to un…未说明篇幅
- research letterResearch Letter: Word count up to 1500. A concise report of original research with up to 10 references and up to 2 tables or figures.未说明篇幅
- reviewPlease note: There is no limit on the number of tables, figures or references that can accompany an article. Information that is relevant but not critical to un…未说明篇幅
- review articlePlease note: There is no limit on the number of tables, figures or references that can accompany an article. Information that is relevant but not critical to un…未说明篇幅
- summary of research article (sra)Summary of Research Article (SRA): A standalone summary of a source article previously published in an Adis journal, or in a journal from another publisher.未说明篇幅
- systematic reviewPlease note: There is no limit on the number of tables, figures or references that can accompany an article. Information that is relevant but not critical to un…未说明篇幅
官网政策摘录AI 使用、作者资格、利益冲突、数据可用性、许可与版权、开放获取、试验注册 / 报告规范
- AI 使用 Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
原文 ↗出版商官网 ·- 作者资格 Authorship Principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
原文 ↗出版商官网 ·- 利益冲突 Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
原文 ↗出版商官网 ·- 数据可用性 Data availability statements
Data availability statement required for all original research 模型摘要
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
原文 ↗出版商官网 ·- 许可与版权 Copyright and license term – CC BY-NC
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under the Creative Commons Attribution-NonCommercial 4.0 International License Find more about the license agreement Back to top
原文 ↗出版商官网 ·- 开放获取 Open access publishing
Open Choice articles published under CC BY-NC 4.0 模型摘要
To find out more about publishing your work Open Access in Pharmaceutical Medicine, including information on fees, funding and licences, visit our Open access publishing page. Back to top
原文 ↗出版商官网 ·- 试验注册 / 报告规范 Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
原文 ↗出版商官网 ·
摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。
基本信息
出版信息与官方入口
- 出版商
- Springer Nature
- 出版周期
- 6 issues per year
- ISSN
- 1178-2595
- 电子版 ISSN
- 1179-1993
- 官网最新一期
- Volume 40, Issue 5（2026 年 9 月）
- 官方链接
- 期刊主页 ↗OpenAlex
- 投稿系统 ↗LetPub
- 作者指南 ↗LetPub
- 专刊 / 特刊征稿 ↗出版商官网
常见问题
关于 Pharmaceutical Medicine 的常见问题
Pharmaceutical Medicine 是中科院几区期刊？
2025 年升级版分区表中，Pharmaceutical Medicine 为医学 4区，小类 药学 4 区。2026 年新锐版分区表中为医学 3区。不同版本与大小类分区不能混用。
Pharmaceutical Medicine 的影响因子是多少？
期刊官网公布的影响因子为 4.7（2025 年度），属期刊自述数据，LetPub 暂无该刊的影响因子记录，CiteScore 为 8.4，h-index 为 38。
Pharmaceutical Medicine 的审稿周期多长？
出版商公布的投稿到首次决定时间约为 10 天（首次决定含直接拒稿）。文章统计只含被录用的稿件，出版商数据口径以官网为准，社区反馈来自投稿者样本，均不代表期刊承诺。
Pharmaceutical Medicine 的投稿格式要求是什么？
据期刊作者指南：摘要：150–250 词；参考文献格式：顺序编码制（按引用顺序编号）；推荐审稿人：可选；投稿信：必须提供。以上由模型从作者指南提取并逐项与原文核对，投稿前请以官网最新版本为准。
Pharmaceutical Medicine 的编委会里有中国学者吗？
期刊官网编委会页面上标注了国家的 47 位编委中，没有中国大陆学者；人数最多的国家是 新西兰（11 位）、美国（9 位）、英国（8 位）。统计按编委会页面列出的机构国家计，仅供参考。
Pharmaceutical Medicine 被哪些数据库收录？
据 LetPub 与 DOAJ 记录，Pharmaceutical Medicine 被 ESCI、Scopus 收录。期刊官网自述还被 MEDLINE、Embase、CAS 收录，该清单未与各数据库逐一核对。
Pharmaceutical Medicine 是开放获取期刊吗？版面费多少？
Pharmaceutical Medicine 为混合开放获取。选择开放获取发表时APC 约 4,290 美元。
来源与更新
本页事实来自 LetPub、OpenAlex、出版商官网；每个数字旁标注来源与观测日期，冲突数据保留各来源原值。LetPub 原始详情页：查看 ↗（2026-08-26 归档）。最近更新：。